Foot Locker Stock a...
Health Care: Drugs
Raptor Pharmaceutical Corp (RPTP: NASDAQ)
$7.79 -0.04 | -0.51%
06/19/13 - 04:00 PM ET
Company Balance Sheet
| Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 23.58M | 15.17M | 16.95M | 3.70M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 42.17M | 15.70M | 17.24M | 3.81M |
| Property, Plant & Equipment, Gross | 949.00K | 558.26K | 509.11K | 488.36K |
| Accumulated Depreciation & Depletion | 546.00K | 481.26K | 415.86K | 343.62K |
| Property, Plant & Equipment, Net | 403.00K | 77.00K | 93.25K | 144.74K |
| Intangibles | 2.20M | 3.25M | 3.51M | 2.52M |
| Other Non-Current Assets | 239.00K | 104.91K | 102.91K | 100.21K |
| Total Non-Current Assets | 6.12M | 6.86M | 7.15M | 2.77M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 48.29M | 22.56M | 24.39M | 6.58M |
| Accounts Payable | 1.60M | 847.14K | 637.32K | 613.58K |
| Short Term Debt | 8.00K | 3.95K | 4.86K | 4.12K |
| Other Current Liabilities | 17.27M | 23.58M | 15.78M | 0.00 |
| Total Current Liabilities | 21.54M | 26.70M | 17.55M | 1.07M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 13.00K | 9.78K | 1.81K | 6.68K |
| Total Liabilities | 21.55M | 26.71M | 17.56M | 1.08M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 26.74M | -4.15M | 6.83M | 5.50M |
| Common Par | 51.00K | 35.57K | 30.08K | 17.86K |
| Additional Paid In Capital | 143.38M | 73.82M | 47.62M | 27.36M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -116.65M | -78.00M | -40.81M | -21.88M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -50.00K | 1.90K | -7.85K | 0.00 |
| Total Capitalization | 26.74M | -4.15M | 6.83M | 5.50M |
| Total Equity | 26.74M | -4.15M | 6.83M | 5.50M |
| Total Liabilities & Stock Equity | 48.29M | 22.56M | 24.39M | 6.58M |
| Total Common Shares Outstanding | 50.57M | 35.57M | 30.08M | 17.86M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 48.08M | 32.33M | 22.23M | 14.44M |
| Diluted Weighted Shares Outstanding | 48.08M | 32.33M | 22.23M | 14.44M |
| Number of Employees | 36 | 12 | 10 | 12 |
| Number of Part-Time Employees | 2 | 2 | 1 | 0 |
Portfolios with RPTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserTrashy77 - 20110803
- ContributorHeavily Shorted Market Lead...
Latest RPTP Headlines from TheStreet
- Raptor's PROCYSBI(TM) Now Commercially Available In The U.S. For Nephropathic Cystinosis Patients 06.19.13 | 07:06 am
- Raptor Pharmaceutical To Present At Upcoming Investor Conference 06.12.13 | 07:06 am
- Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results 05.08.13 | 04:05 pm
- Raptor Pharmaceutical Licenses Intellectual Property For Rett Syndrome From French Research Institutes 05.07.13 | 07:05 am
- 5 Stocks Under $10 Set to Surge 05.02.13 | 02:05 pm
- Raptor's FDA Approval Is New Test For Orphan Drug Pricing 05.01.13 | 07:05 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Raptor Pharmaceutical Corp. Reports Financial Results For The Transition Period From September 1, 2012 To December 31, 2012 03.14.13 | 04:03 pm
- 5 Stocks Under $10 Set to Soar 03.07.13 | 01:03 pm
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
Press Releases for RPTP
- Record Use Of At-the-Market (ATM) Offerings Continues In 2013 With $161 Million Raised By U.S. Life Sciences Companies In First Quarter, Reports Brinson Patrick - PR Newswire 05.28.13 | 08:05 am
- Multimedia Now Available: Raptor Pharmaceutical's PROCYSBIâ¿¢ Receives FDA Approval For The Treatment Of Nephropathic Cystinosis - PR Newswire 05.01.13 | 04:05 pm
- Raptor Pharmaceutical's PROCYSBIâ¿¢ Receives FDA Approval For The Treatment Of Nephropathic Cystinosis - PR Newswire 04.30.13 | 03:04 pm
- SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Raptor Pharmaceuticals Corp. - Business Wire 02.12.13 | 10:02 am
- Faruqi & Faruqi, LLP Is Investigating Raptor Pharmaceutical Corporation On Behalf Of Its Shareholders - RPTP - PR Newswire 02.12.13 | 08:02 am
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Raptor Pharmaceuticals Corp. In Connection With Executive Compensation - PR Newswire 01.23.13 | 02:01 pm
- HealthCare Royalty Partners Commits Over $300 Million In New Investments In December And Over $425 Million In 2012 - PR Newswire 01.03.13 | 08:01 am
Partner Headlines for RPTP
- Raptor To Rise On Proven Strategy & Upcoming FDA Decision - Seeking Alpha 12.28.12 | 09:12 am
- Three Compelling Biopharma Stocks For 2013 - Seeking Alpha 12.26.12 | 09:12 am
- Healthcare Biz Recap: HGSI Shareholder Sues, Endo Health Kisses Watson Pharma - Wall St. Cheat Sheet 05.29.12 | 11:05 am
- Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical Journal of the American Society of Nephrology - Benzinga 05.03.12 | 01:05 pm
- Raptor Pharmaceutical Stockholder Meeting Adjourned due to Lack of Requisite Quorum - Benzinga 04.26.12 | 01:04 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Raptor Pharmaceuticals Provides Update On Lead Candidate: RP103 - Seeking Alpha 10.31.11 | 08:10 am
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
